4SC AG
Biopharmaceutical company with no products under development or operational business.
VSC | F
Overview
Corporate Details
- ISIN(s):
- DE000A3E5C40
- LEI:
- 391200QOKN7LGVP0RQ86
- Country:
- Germany
- Address:
- Fraunhoferstr. 22, 82152 Planegg
- Website:
- https://www.4sc.com/
- Sector:
- Manufacturing
Description
4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2017-03-31 00:00 |
Annual financial report 2016
|
German | PDF • 4.3 MB | ||
| 2017-03-29 07:30 |
4SC AG announces results for financial year 2016
|
English | HTML • 18.9 KB | ||
| 2017-03-22 07:30 |
4SC AG: Conference call to be hosted on 29 March 2017 to present annual results…
|
English | HTML • 8.7 KB | ||
| 2017-03-21 07:30 |
4SC-202 - a promising combination partner for cancer treatment
|
English | HTML • 17.9 KB | ||
| 2017-02-17 10:11 | English | HTML • 2.1 KB | |||
| 2017-02-17 09:38 | English | HTML • 2.2 KB | |||
| 2017-02-17 00:00 |
Datum:17.02.2017
|
German | HTML • 11.1 KB | ||
| 2017-01-24 12:23 |
4SC AG: Overall survival benefit for resminostat in first-line liver cancer stu…
|
English | HTML • 17.1 KB | ||
| 2016-12-16 07:30 |
4SC AG: First patient enrolled in pivotal RESMAIN study of resminostat in CTCL
|
English | HTML • 14.7 KB | ||
| 2016-11-10 07:30 |
4SC AG: 4SC provides Q3 2016 update
|
English | HTML • 18.5 KB | ||
| 2016-11-10 00:00 |
Q3 statement / Q3 financial report 2016
|
English | PDF • 82.4 KB | ||
| 2016-11-03 09:58 |
4SC AG: Conference call to be hosted on 10 November 2016 to present 9M 2016 int…
|
English | HTML • 8.5 KB | ||
| 2016-10-21 11:18 |
4SC AG: Dr Daniel Vitt to step down as CDO/CSO and from the Management Board at…
|
English | HTML • 5.5 KB | ||
| 2016-10-06 07:30 |
DGAP-DD: 4SC AG english
|
English | HTML • 8.1 KB | ||
| 2016-10-05 10:32 |
4SC AG: Subgroup analysis suggests survival benefit in patients with advanced l…
|
English | HTML • 5.2 KB |
Automate Your Workflow. Get a real-time feed of all 4SC AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for 4SC AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for 4SC AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
